PMID: 7058762Feb 18, 1982

Pharmacokinetics of diltiazem in selected animal species and human beings

The American Journal of Cardiology
R W PiephoR K Browne

Abstract

The absorption, distribution and elimination of diltiazem hydrochloride in rodent and canine species are reviewed. The drug is well absorbed but undergoes first pass metabolism after oral administration. Diltiazem is extensively distributed, and 52 to 81 percent is bound to serum protein, depending on the species studied. Diltiazem is metabolized in the liver by several pathways; deacetylation, N-demethylation, and O-demethylation are the primary degradative steps. The metabolites are excreted in urine and feces, indicating that biliary excretion occurs. There is some evidence for enterohepatic cycling. Diltiazem is rapidly eliminated (t 1/2 = 2.24 hours) in beagle dogs, and the relatively short half-life appears to be a result of the high level of plasma clearance (46.1 +/- 4.8 ml/min/per kg body weight). A comparison of the plasma diltiazem clearance with hepatic blood flow in the dog indicates that the drug is eliminated at a rate dependent on hepatic blood flow.

References

Aug 1, 1979·Journal of Pharmaceutical Sciences·L Z Benet, R L Galeazzi
Jul 1, 1980·Chest·J S SchroederI Lamb
Apr 1, 1982·Journal of Clinical Pharmacology·D C BloedowJ Gal

Citations

Nov 1, 1995·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·M al EdreesiK Paradis
May 22, 1998·Journal of Veterinary Internal Medicine·K L Cooke, P S Snyder
Aug 10, 2000·Journal of Veterinary Internal Medicine·M MiyamotoR L Hamlin
Apr 1, 1991·European Journal of Drug Metabolism and Pharmacokinetics·G CailléM G Grace
Oct 1, 1992·European Journal of Drug Metabolism and Pharmacokinetics·R BernasconiA Salimbeni
Jan 1, 1983·Pharmacology & Therapeutics·A G Ellrodt, B N Singh
Mar 1, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S RuedaC Solans
Sep 1, 1988·American Journal of Obstetrics and Gynecology·R H HolbrookE M Voss
Jun 15, 2007·Journal of Pharmacological and Toxicological Methods·Facundo M BerteraChristian Höcht
May 4, 2006·Journal of Veterinary Pharmacology and Therapeutics·C C SchwarzwaldJ D Bonagura
Nov 7, 2006·Journal of Veterinary Pharmacology and Therapeutics·C C Schwarzwald, R A Sams
May 1, 1983·The American Journal of Cardiology·M S SmithE L Pritchett
Oct 1, 1991·Annals of Emergency Medicine·E V CapparelliM S Chow
Apr 1, 1984·Journal of the American College of Cardiology·R W WalshR A O'Rourke
Dec 6, 1985·The American Journal of Cardiology·R W Piepho
Jan 1, 1985·Reviews on Drug Metabolism and Drug Interactions·R L Klieman, S H Stephenson
Jun 1, 1986·Journal of Clinical and Hospital Pharmacy·M J Kendall, J V Okopski
Aug 1, 1987·British Journal of Clinical Pharmacology·S C Montamat, D R Abernethy
Jan 25, 1985·The American Journal of Cardiology·R G McAllisterR A Blouin
Jan 1, 1983·European Journal of Clinical Pharmacology·P HermannP L Morselli
May 8, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xin ZhangStephen D Hall
Jan 1, 1984·Acta Medica Scandinavica. Supplementum·L StorsteinL Saevareid
Mar 21, 2002·The Journal of Pharmacy and Pharmacology·Yuichiro AdachiKazuhiko Tamura
Jun 25, 2017·European Journal of Drug Metabolism and Pharmacokinetics·Xiao-Feng GuanXiao-Cong Zuo
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoichi NaritomiYuichi Sugiyama
May 1, 1988·Journal of Clinical Pharmacology·O Grech-BélangerE LeBoeuf
Jan 1, 1985·Acta Pharmacologica Et Toxicologica·P Hermann, P L Morselli
May 1, 1982·Pharmacotherapy·B J McAuley, J S Schroeder

Related Concepts

Benzazepines
Metabolic Biotransformation
Cebidae
Aldizem
Canis familiaris
Intestinal Absorption
Maternal-Fetal Exchange
Total Body Clearance Rate
Plasma Protein Binding Capacity
August Rats

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.